Skip to main content

Table 1 Demographic and clinical baseline data of the 125 patients of the main study (33) and of the subgroup of 93 women with menstrually related migraine

From: Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan

 

Main study n = 125

Menstruating Women n = 93

p

Age (years, means ± SD)

37 ± 9

36 ± 9

NS

Height (cm, means ± SD)

167 ± 9

163 ± 7

<0.01

Weight (kg, means ± SD)

64 ± 13

59 ± 8

<0.01

Age at onset of migraine (years, means ± SD)

16 ± 7

16 ± 6

NS

Migraine attack duration >2 days (n, %)

26 (21)

25 (28)

NS

MIDAS score (means ± SD)

22 ± 15

26 ± 17

<0.05

  1. Data are shown as mean (±SD), or absolute (n) and relative frequency (%)